Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Aehr Test Systems climbs as investors focus on record AI order and cleared equity-offering overhang

None

Aehr Test Systems (AEHR) is up 5.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The move higher appears tied to continued bullish follow-through from Aehr’s recently announced record production order tied to AI data-center processors, alongside relief that the company has finished a previously disclosed at-the-market (ATM) equity program (which can remove a near-term dilution/selling overhang). If there was no single new headline today, the gain could also be driven by momentum trading after these April catalysts.

Details:

  • Aehr announced a record $41 million follow-on production order from its lead hyperscale customer for package-level burn-in of custom AI processor ASICs.
  • The company said the order includes Sonoma package-level test and burn-in systems plus related consumables (turnkey burn-in modules and device-specific sockets), with deliveries expected to begin in fiscal 2027 (starting June 27, 2026).
  • Aehr also stated that this order pushed second-half fiscal 2026 bookings to more than $92 million to date (as of the announcement).
  • In an SEC filing, Aehr disclosed it fully utilized its ATM equity offering program, completing sales that generated approximately $60.0 million in gross proceeds, which may have reduced uncertainty around ongoing share issuance.
  • Sources:

    Aehr Test Systems (press release), U.S. SEC (Form 8-K)

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $AEHR Insider Trading Activity

    AEHR Insider Trades

    $AEHR insiders have traded $AEHR stock on the open market 48 times in the past 6 months. Of those trades, 0 have been purchases and 48 have been sales.

    Here’s a breakdown of recent trading of $AEHR stock by insiders over the last 6 months:

    • GAYN ERICKSON (President and CEO) has made 0 purchases and 2 sales selling 152,824 shares for an estimated $10,786,791.
    • GEOFFREY GATES SCOTT (Director) has made 0 purchases and 5 sales selling 95,000 shares for an estimated $8,033,250.
    • RHEA J POSEDEL (Director) has made 0 purchases and 8 sales selling 100,504 shares for an estimated $7,619,263.
    • ALBERTO SALAMONE (EVP, PPBI BUSINESS) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $2,761,950.
    • VERNON ROGERS (Exec VP of Sales & Mktg.) has made 0 purchases and 5 sales selling 29,805 shares for an estimated $2,475,620.
    • DONALD P. II RICHMOND (CTO) has made 0 purchases and 2 sales selling 32,762 shares for an estimated $2,326,659.
    • HOWARD T SLAYEN (Director) has made 0 purchases and 2 sales selling 31,000 shares for an estimated $2,279,357.
    • FARIBA DANESH (Director) has made 0 purchases and 3 sales selling 18,500 shares for an estimated $1,406,628.
    • ADIL ENGINEER (Chief Operating Officer) has made 0 purchases and 4 sales selling 16,813 shares for an estimated $1,139,350.
    • LAURA OLIPHANT (Director) has made 0 purchases and 8 sales selling 13,927 shares for an estimated $887,013.
    • ALISTAIR N SPORCK (VP Contactor Business Unit) has made 0 purchases and 5 sales selling 9,000 shares for an estimated $568,196.
    • DIDIER WIMMERS (Executive VP of R&D) has made 0 purchases and 2 sales selling 5,400 shares for an estimated $385,731.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

    $AEHR Hedge Fund Activity

    We have seen 89 institutional investors add shares of $AEHR stock to their portfolio, and 72 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

    $AEHR Analyst Ratings

    Wall Street analysts have issued reports on $AEHR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • William Blair issued a "Outperform" rating on 03/02/2026

    To track analyst ratings and price targets for $AEHR, check out Quiver Quantitative's $AEHR forecast page.

    $AEHR Price Targets

    Multiple analysts have issued price targets for $AEHR recently. We have seen 2 analysts offer price targets for $AEHR in the last 6 months, with a median target of $25.0.

    Here are some recent targets:

    • Christian Schwab from Craig-Hallum set a target price of $21.0 on 01/09/2026
    • An analyst from Lake Street set a target price of $29.0 on 12/17/2025

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles